| Term 
 
        | Tolterodine - Overactive Bladder |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Oxybutynin - Overactive Bladder |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Darifenacin - Overactive Bladder |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Solifenacin - Overactive Bladder |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Trospium- Overactive Bladder |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Fesoterodine - Overactive Bladder |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Flavoxate - Overactive Bladder |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Propantheline - GI/IBS/Pre-Op |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dicyclomine - GI/IBS/Pre-Op |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Glycopyrrolate - GI/IBS/Pre-Op |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tropicamide -mydriasis/cylcoplegia |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tropicamide/Hydroxyamphetamine -mydriasis/cylcoplegia |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Cyclopentolate -mydriasis/cylcoplegia |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Pancuronium- Non depolarizing blocking agent |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Succinylcholine - depolarizing blocking agent |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Norepinephrine - Direct acting NS |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Epinephrine - Direct acting NS |  | Definition 
 
        | (Adrenalin) α1, α2, β1, β2 |  | 
        |  | 
        
        | Term 
 
        | Isoproterenol - Direct acting NS |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dobutamine - Direct acting NS |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Fenoldopam - Direct acting NS |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Carvedilol - antioxidant (non class effect) decrease apoptosis |  | Definition 
 
        | Coreg β1, β2, possibly α1 |  | 
        |  | 
        
        | Term 
 
        | Captopril -1st ACEi; caused blood dyscrasia; reduce dose made more effective |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vasotec (Enalaprilat - Vasotec I.V.) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Losartan - ARB prodrug weak; active metabolite uricosuric
 reversible
 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Candesartan - ARB prodrug -activated in intestine not kidney irreversible
 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Olmesartan - ARB prodrug activated in intestine not kidney
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aliskiren - NOT used for CHF Renin inhibitor
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Nesiritide - atrial natriurectic factor recombinate form of B-NF
 dilatione, used for acute decompensated CHF, more cGMP
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Chlorothiazide -thiazide high dose needed for same efficacy
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Hydrochlorothiazide (HCTZ) -thiazide low dose needed for same efficacy
 |  | Definition 
 
        | Hydrodiuril, Esidrix, Oretic |  | 
        |  | 
        
        | Term 
 
        | Methyclothiazide -thiazide |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Furosemide -loop diuretic |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Ethacrynic acid -loop diuretic |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Bumetanide -loop diuretic |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Triamterene - K sparing diuretic bind to Na channel
 no effect on aldosterone
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amiloride - K sparing diuretic |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Spironolactone - K sparing diuretic bind to MR receptor
 reduce effect on aldosterone
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Eplerenone - K sparing diuretic similar to spironolactone but no hormone effects
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Mannitol - osmotic diuretic |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Glycerin - osmotic diuretic |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Acetazolamide - carbonic anhydrase inhibitor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Methazolamide - carbonic anhydrase inhibitor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Digoxin - cardiac glycoside block Na/K ATPase --> inc Ca
 toxic
 |  | Definition 
 
        | Lanoxin -yellow 125; white 250 |  | 
        |  | 
        
        | Term 
 
        | Digoxin Immune Fab Fragments (ovine) - cardiac glycoside |  | Definition 
 
        | Digibind (antidote for Dig toxicity) |  | 
        |  | 
        
        | Term 
 
        | Dopamine - direct & indirect - adrenergic agonist |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dobutamine - adrenergic agonist; direct |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Amrinone -PDE III inhibitor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Milrinone -PDE III inhibitor |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibitors of Cyclooxygenase |  | 
        |  | 
        
        | Term 
 
        | Clopidogrel - inhibitor of ADP |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dipyridamole -PDE V inhibitor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Abciximab -GP IIb/IIIb receptor blocking agent chimeric monoclonal Ab FAB frag
 irreversible
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tirofiban -GP IIb/IIIb receptor blocking agent nonpeptide inhibitor; RGD mimic
 reversible
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Eptifibatide -GP IIb/IIIb receptor blocking agent synthetic peptide; cyclic RGD peptide; stable
 reversible
 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Fondaparinux -Indirect Thrombin Inhibitors Injection; only pentasach; need AT3
 Kidney; no antidote
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Rivaroxaban -Indirect Thrombin Inhibitors don't need AT3; PO; liver;
 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct Thrombin Inhibitors |  | 
        |  | 
        
        | Term 
 
        | Recombinant hirudin - Direct Thrombin Inhibitors |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Bivalirudin - Direct Thrombin Inhibitors doesn't last long
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Argatroban - Direct Thrombin Inhibitors rapid & short duration
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Desirudin - Direct Thrombin Inhibitors SQ
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dabigatran - Direct Thrombin Inhibitors POBID
 acid environment required
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Warfarin - inhibitor of synthesis of Vit K dependent Coagulation factors(2, 7, 9, 10, protein C & S) |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Streptokinase -Thrombolytic agent NS; nondirect
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Urokinase -Thrombolytic agent direct; NS; not widely used
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | APSAC (acylated plasminogen streptokinase activator complex) - Thrombolytic agent possible fibrin selective
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | tPA - alteplase -Thrombolytic agent frequent bleeding @ high dose; fibrin selective
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | rPA -reteplase -Thrombolytic agent long duration; less binding & affinity; penetrate longer
 fibrin selective
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Tenecteplase -Thrombolytic agent not inhibited by PAI
 fibrin selective
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Drotrecogin alfa activated - activated protein C anticoagulant
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Epsilon aminocaproic acid - binds to lysine-binding sites on both plasminogen and plasmin anticoagulant
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Aprotinin -taken off market; lots of death; blocked plasmin, tPA & factor 12a anticoagulant
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Benazepril and amlodipine |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Trandolapril and verapamil |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Olmesartan and Amlodipine |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Triamterene / Hydrochlorothiazide |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Lisinopril / Hydrochlorothiazide |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Valsartan / Hydrochlorothiazide |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Losartan potassium / Hydrochlorothiazide |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Olmesartan / Hydrochlorothiazide |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Trandate, Normodyne B1, B2 maybe a1 |  | 
        |  | 
        
        | Term 
 
        | Dorzolamide - Carbonic anhydrase inhibitor Gluacoma
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Brinzolamide - Carbonic anhydrase inhibitor Gluacoma
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Vaprisol - non selective AVP blocker |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Samsca - V2 selective AVP blocker |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dichlorophenamide - Carbonic anhydrase inhibitor |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Exanta - Off market, Direct Thrombin Inhibitor |  | Definition 
 
        | Ximegalatran- hepatic damage |  | 
        |  | 
        
        | Term 
 
        | Telmisartan + Hydrochlorothiazide- ARB combination |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Eprosartan Mesylate + Hydrochlorothiazide ARB combination |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Irbesartan + HCTZ - ARB combination |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dorzolamide and Timolol - Carbonic anhydrase inhibitor Gluacoma
 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | diagnostic agent-mydriasis/cylcoplegia |  | 
        |  | 
        
        | Term 
 
        | Infliximab - Anti TNF chimeric monoclonal AB |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adalimumab - Anti TNF chimeric monoclonal AB |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits activated: 2, 7, 9, 10, 11 & 12 indirect thrombin inhibitors
 Negative charge- Kidney excretion
 |  | 
        |  |